Bridging with rivaroxaban in patients with chronic use of vitamin K antagonists

Trial Profile

Bridging with rivaroxaban in patients with chronic use of vitamin K antagonists

Not stated
Phase of Trial: Phase III

Latest Information Update: 31 Aug 2011

At a glance

  • Drugs Rivaroxaban (Primary) ; Enoxaparin sodium
  • Indications Thromboembolism
  • Focus Therapeutic Use
  • Most Recent Events

    • 31 Aug 2011 Results presented at the ESC Congress 2011: Annual Congress of the European Society of Cardiology.
    • 31 Aug 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top